Overview
An established pharmaceutical formulation manufacturing company specializing primarily in contract manufacturing of Non-Beta Lectum products, including tablets, capsules, liquid syrups, and ointments. The company operates a modern manufacturing facility established in March 2024, designed in compliance with WHO-GMP standards, with WHO-GMP certification currently under process and expected within the next 3–4 months. The facility has an installed capacity of approximately 15 lakh tablets, 4 lakh capsules, 50,000 liquid syrup bottles, and 50,000 ointment tubes per shift, with operations conducted for approximately 10 hours per day. Current capacity utilization is around 30%, providing substantial headroom for growth. The company is actively making 1,000+ approved formulations and a portfolio of approximately 10,000 product approvals/registrations, enabling it to cater to a wide range of pharmaceutical requirements. It serves established multinational and domestic pharmaceutical companies through contract manufacturing arrangements. The business has recently secured an export order valued at approximately ₹5 crore for its own products and currently has approximately ₹8 crore worth of pending production orders, providing strong near-term revenue visibility. In addition to manufacturing operations, the company generates approximately ₹55 lakh annually in rental income from a portion of its factory land and building.
Owned Pharmaceutical Industry Formulation
Business Details
2024
Year of Establishment
100
No. of Employees
Running Profitable
Current Status of Business
NoBusiness Relocatable
OwnedProperty Type
18 Crs Property Value
Industrial
Property Classification
Describe Property
Company has land and building which is in center of Kala Amb Industrial Area, having around 8,500 sq yards of land and approximately 80,000 sq ft constructed area out of which 36,000 company has rented out for a monthly rent of Rs 4.75 lacs and 25000sqft is used for own manufacturing facility. Even total constructed area can be increased to 1,50,000 sq ft.
Competition / Market
Accross India
Products & Services
Company is in to contract manufacturing business majorly, we are into manufacturing of Non Beta Lactum Tablets, Capsules, Liquid Syrups and Ointments, Rest company is majorly into contract manufacturing business. Company has around 1000+ formulations approval. Company has manufacturing capacity of around 15 lacs tablets, 3.5 lac capsules, 50000 liquid syrups bottle and 50000 ointments per day. Company on an average operates 10 hours per day.
Growth Potential
Company is on ARR of Rs 25 Cr for FY 26-17, and expected to generate EBIDTA of Rs 3.5 Cr. Even at present company is working at around 50% of installed production capacity. As business of company is growing its it expected that company will achieve 90% capacity utilisation in next 3-4 months.
Reason For Sale
Promotors are from other city and dont want to Relocating to kala Amb and travelling is a bit challenge.
Financial Details
EBITDA :-
3.5 Crs
PAT :-
1.3 Crs
Debt :-
7 Crs
How the Acquisition Process Works
- 01Share Your RequirementsDefine your acquisition goals and preferences.
- 02Explore OpportunitiesReview curated businesses matching your criteria.
- 03Evaluate & ValueAnalyse financials, potential, and valuation.
- 04Due DiligenceVerify business, legal, and financial aspects.
- 05Complete AcquisitionNegotiate, close, and take ownership.